Diversity by Design with TriNetX RWD

Diversity by Design: Ensuring More Inclusive Studies with TriNetX Real-World Data

Having representative patient populations in your trial designs is crucial to understanding disease and designing successful clinical trials. Evaluating patient eligibility criteria and its impact on enrollment helps us anticipate and adjust these criteria when it’s most crucial: before your study even begins.

Stream our webinar, aired on June 13th to hear from Beth Brooks, Head of Patient Insights and Behavioral Sciences at Sanofi, who will share how utilizing TriNetX has improved her team’s research outcomes from protocol to results. We will also be joined by a member of our TriNetX Clinical Feasibility & Analytics team to share best practices when querying diverse patient populations.


Beth Brooks, MPH
Head, Patient Insights & Behavioral Sciences

Isatu Kargbo
Senior Analyst, Clinical Feasibility & Analytics​

Jim Phillips
VP Account Management

Complete this form to stream the webinar now.